Deltex Medical Group (DEMG)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 1.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.00p
  • 52 Week Low: 0.76p
  • Currency: UK Pounds
  • Shares Issued: 512.27m
  • Volume: 291,590
  • Market Cap: £9.22m
  • RiskGrade: 302

Deltex makes 'significant reduction' in costs

By Iain Gilbert

Date: Friday 25 Jan 2019

LONDON (ShareCast) - (Sharecast News) - Doppler monitoring outfit Deltex Medical has seen a significant reduction in costs following the implementation of its new strategy.
Deltex said it was able to deliver "substantially improved profitability and cash generation" during the three months ended 31 December and now expects that it will be EBITDA positive in the new year.

While Deltex expected lower levels of revenues during the initial phase of the implementation as it switched its focus towards driving revenues from existing customers, the targeted approach offset much of those concerns as several other costs were able to be "significantly reduced".

Overall, the AIM-listed firm recorded revenues slightly behind expectations at approximately £5m, while full-year losses before exceptional items were expected to be "broadly in line with market expectations".

Gross cash was up 200% at £600,000.

Chairman Nigel Keen said: "The initial results from the new business strategy of building a more stable business as a result of improved profitability and cash generation are most encouraging; we are looking forward to seeing further progress during 2019."

As of 0840 GMT, Deltex shares had shot up 15.79% to 1.10p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DEMG Market Data

Currency UK Pounds
Share Price 1.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.00p
52 Week Low 0.76p
Volume 291,590
Shares Issued 512.27m
Market Cap £9.22m
RiskGrade 302

DEMG Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.95% below the market average45.95% below the market average45.95% below the market average45.95% below the market average45.95% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Price Trend
53.21% above the market average53.21% above the market average53.21% above the market average53.21% above the market average53.21% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income Not Available
Growth
52.79% below the market average52.79% below the market average52.79% below the market average52.79% below the market average52.79% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DEMG Dividends

No dividends found

Trades for 19-Jun-2019

Time Volume / Share Price
15:36 41,590 @ 1.74p
09:38 250,000 @ 1.88p

DEMG Key Personnel

Chair Nigel J Keen
Finance Director Jonathan David Shaw
CEO Andy Mears

Top of Page